Arcus Biosciences, Inc. ( RCUS) - Key Metrics
RCUS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.31 | -$0.91 | -$1.12 | -$1.13 |
| 2025Q3 | $0.24 | -$1.27 | -$0.91 | -$0.91 |
| 2025Q2 | $1.51 | -$0.08 | -$1.25 | -$1.25 |
| 2025Q1 | $0.28 | -$1.14 | -$1.34 | -$1.35 |
RCUS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -6.53 |
| 2025Q3 | ? | -2.68 |
| 2025Q2 | ? | -26.99 |
| 2025Q1 | ? | -1.72 |
RCUS
Price: $24.18
52 week price:
Earnings Per Share: -3.17 USD
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 965900
Market Capitalization: 2.3 billion